The information pathway to randomisation: patients experience of the mesothelioma and radical surgery (MARS2) feasibility trial

Tod, A. orcid.org/0000-0001-6336-3747, Warnock, C., Lord, K. et al. (1 more author) (2018) The information pathway to randomisation: patients experience of the mesothelioma and radical surgery (MARS2) feasibility trial. In: Journal of Thoracic Oncology. IASLC 19th World Conference on Lung Cancer, 23-26 Sep 2018, Toronto, Canada. Elsevier , S396-S396.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier. This is an author produced version of a paper subsequently published in Journal of Thoracic Oncology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Longitudinal qualitative research; Mesothelioma; patient experience
Dates:
  • Published (online): 22 October 2018
  • Published: 22 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Nursing and Midwifery (Sheffield)
Funding Information:
FunderGrant number
JOHN PICKERING AND PARTNERS' CHARITABLE TRUSTUNSPECIFIED
Depositing User: Symplectic Sheffield
Date Deposited: 18 Jan 2019 10:51
Last Modified: 22 Oct 2019 00:39
Published Version: https://doi.org/10.1016/j.jtho.2018.08.412
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jtho.2018.08.412
Related URLs:

Share / Export

Statistics